• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泰利霉素(HMR 3647)对希腊不同大环内酯敏感性的化脓性链球菌和肺炎链球菌临床分离株的体外活性。

In vitro activity of telithromycin (HMR 3647) against Greek Streptococcus pyogenes and Streptococcus pneumoniae clinical isolates with different macrolide susceptibilities.

作者信息

Ioannidou S, Tassios P T, Zachariadou L, Salem Z, Kanelopoulou M, Kanavaki S, Chronopoulou G, Petropoulou N, Foustoukou M, Pangalis A, Trikka-Graphakos E, Papafraggas E, Vatopoulos A C

机构信息

Department of Hygiene and Epidemiology, Medical School, Athens University, 115 27 Athens (Goudi), Greece.

出版信息

Clin Microbiol Infect. 2003 Jul;9(7):704-7. doi: 10.1046/j.1469-0691.2003.00572.x.

DOI:10.1046/j.1469-0691.2003.00572.x
PMID:12925112
Abstract

The susceptibilities to macrolides and telithromycin of 161 Streptococcus pyogenes and 145 Streptococcus pyogenes strains, consecutively isolated from five Greek hospitals, were determined by Etest. Moreover, mechanisms of resistance to macrolides were phenotypically and genetically determined by double disk induction test and PCR, respectively. Of the S. pneumoniae and S. pyogenes isolates, 42.8% and 30.8%, respectively, were found to be resistant to erythromycin. Of the erythromycin-resistant S. pneumoniae and S. pyogenes isolates, 57.5% and 59.5%, respectively, displayed the M phenotype and harbored the mefA/E gene. Telithromycin was found to be more active than both erythromycin and clarithromycin against both species, with considerably lower MIC50 and MIC90 values.

摘要

采用Etest法测定了从希腊五家医院连续分离出的161株化脓性链球菌和145株化脓性链球菌对大环内酯类药物和泰利霉素的敏感性。此外,分别通过双纸片诱导试验和PCR从表型和基因水平确定了对大环内酯类药物的耐药机制。在肺炎链球菌和化脓性链球菌分离株中,分别有42.8%和30.8%被发现对红霉素耐药。在对红霉素耐药的肺炎链球菌和化脓性链球菌分离株中,分别有57.5%和59.5%表现为M表型并携带mefA/E基因。结果发现,泰利霉素对这两种菌的活性均高于红霉素和克拉霉素,其MIC50和MIC90值显著更低。

相似文献

1
In vitro activity of telithromycin (HMR 3647) against Greek Streptococcus pyogenes and Streptococcus pneumoniae clinical isolates with different macrolide susceptibilities.泰利霉素(HMR 3647)对希腊不同大环内酯敏感性的化脓性链球菌和肺炎链球菌临床分离株的体外活性。
Clin Microbiol Infect. 2003 Jul;9(7):704-7. doi: 10.1046/j.1469-0691.2003.00572.x.
2
Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.16元环大环内酯类药物及泰利霉素对不同基因型的红霉素敏感及耐药化脓性链球菌和肺炎链球菌的活性。
J Antimicrob Chemother. 2007 Jun;59(6):1171-6. doi: 10.1093/jac/dkm089. Epub 2007 Apr 3.
3
In vitro activity of ketolides telithromycin and HMR 3004 against italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility.酮内酯类药物泰利霉素和HMR 3004对意大利不同红霉素敏感性的化脓性链球菌和肺炎链球菌分离株的体外活性
J Antimicrob Chemother. 2000 Dec;46(6):905-8. doi: 10.1093/jac/46.6.905.
4
Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study.化脓性链球菌和肺炎链球菌对大环内酯类药物及泰利霉素的敏感性:一项意大利多中心研究的数据。
J Chemother. 2007 Oct;19(5):500-7. doi: 10.1179/joc.2007.19.5.500.
5
Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes.一种新型氟酮内酯类药物HMR 3787及其(去)氟衍生物RU 64399,与泰利霉素、红霉素A、阿奇霉素、克拉霉素和克林霉素相比,对大环内酯类敏感或耐药的肺炎链球菌和化脓性链球菌的活性。
Antimicrob Agents Chemother. 2001 Nov;45(11):3242-5. doi: 10.1128/AAC.45.11.3242-3245.2001.
6
In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors.新型酮内酯类药物泰利霉素与大环内酯类药物对化脓性链球菌的体外活性比较:耐药机制和方法学因素的影响
Antimicrob Agents Chemother. 2000 Nov;44(11):2999-3002. doi: 10.1128/AAC.44.11.2999-3002.2000.
7
[In vitro susceptibility of respiratory isolates of Streptococcus pneumoniae and Streptococcus pyogenes to telithromycin and 11 other antimicrobial agents: Turkish results of e-BASKETT-II surveillance study].[肺炎链球菌和化脓性链球菌呼吸道分离株对泰利霉素及其他11种抗菌药物的体外敏感性:e-BASKETT-II监测研究的土耳其结果]
Mikrobiyol Bul. 2007 Jan;41(1):1-9.
8
In vitro compared activity of telithromycin and azithromycin against northwest Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility.体外比较泰利霉素和阿奇霉素对意大利西北部不同红霉素敏感性的化脓性链球菌和肺炎链球菌分离株的活性。
Lett Appl Microbiol. 2008 Oct;47(4):309-14. doi: 10.1111/j.1472-765x.2008.02423.x.
9
An examination of the differential sensitivity to ketolide antibiotics in ermB strains of Streptococcus pyogenes and Streptococcus pneumoniae.化脓性链球菌和肺炎链球菌ermB菌株对酮内酯类抗生素的差异敏感性研究。
Curr Microbiol. 2004 Oct;49(4):239-47. doi: 10.1007/s00284-004-4306-7.
10
[Comparison of antimicrobial and bactericidal activities and postantibiotic effects of macrolides antibiotics against clinical isolates, and examination of shape alteration by scanning electron microscope].[大环内酯类抗生素对临床分离株的抗菌和杀菌活性及抗生素后效应比较,以及通过扫描电子显微镜检查形态改变]
Jpn J Antibiot. 2007 Feb;60(1):31-46.

引用本文的文献

1
Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options.多重耐药肺炎链球菌感染:当前及未来的治疗选择
Drugs. 2007;67(16):2355-82. doi: 10.2165/00003495-200767160-00005.
2
Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.两种新型大环内酯类药物GW 773546和GW 708408与红霉素、阿奇霉素、克拉霉素、克林霉素和泰利霉素相比的抗肺炎球菌活性。
Antimicrob Agents Chemother. 2004 Nov;48(11):4103-12. doi: 10.1128/AAC.48.11.4103-4112.2004.